Home
>
US Stocks
>
Scholar Rock Holding Corp

Key Stats

Open
26.46
Today Low/High
26.19 / 27.08
52 Week Low/High
$12.68 / $70
Market Cap
$1.43B

Company Details

Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia. Scholar Rock's approach to targeting the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. By developing product candidates that act in the disease microenvironment, the Company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect. Scholar Rock believes its focus on biologically validated growth factors may facilitate a more efficient development path.
Organisation
Scholar Rock Holding Corp
Headquaters
Cambridge, Massachusetts, United States
Employees
119
Industry
Health Technology
CEO
Nagesh Mahanthappa

Discover more

Frequently Asked Questions

What is Scholar Rock Holding Corp share price today

Can Indians buy Scholar Rock Holding Corp shares?

How can I buy Scholar Rock Holding Corp shares from India?

Can Fractional shares of Scholar Rock Holding Corp be purchased?

What are the documents required to start investing in Scholar Rock Holding Corp stocks?

We are a SEBI registered investement advisor